Marc Dunoyer - Articles and news items


AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K.

Industry news / 26 March 2014 / AstraZeneca

AstraZeneca today announced it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K…


Marc Dunoyer appointed Chief Financial Officer of AstraZeneca

Industry news / 31 October 2013 / AstraZeneca

“Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience…”


AstraZeneca appoints Marc Dunoyer as Executive Vice President, Global Portfolio & Product Strategy

Industry news, News / 21 March 2013 / AstraZeneca

AstraZeneca announced that Marc Dunoyer is to join the company…

GlaxoSmithKline logo

Top-line six-month primary treatment period results from first Phase III Fabry monotherapy study

Industry news, News / 19 December 2012 / GlaxoSmithKline

Six-month primary treatment period results…

GlaxoSmithKline logo

GlaxoSmithKline and Amicus Therapeutics expand Fabry disease collaboration

Industry news, News / 17 July 2012 / GlaxoSmithKline

Fabry products to be commercialised by Amicus in US and by GSK ex-US…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...